Tuesday Video News from the 2009 International Conference on Alzheimer's Disease

Article

The theme for the Tuesday session was “Alzheimer's disease Biomarkers: Update from the Alzheimer's Disease Neuroimaging Initiative.”

Each morning at the 2009 ICAD conference, there is a media session featuring researchers who will be speaking or presenting that day. The session is recorded and posted online as brief videos. The theme for the Tuesday session was “Alzheimer's disease Biomarkers: Update from the Alzheimer's Disease Neuroimaging Initiative.”

Michael Ewers, PhD, Senior Research Fellow, Trinity College Institute of Neuroscience, Trinity College, Dublin, Ireland, discusses multi-dimensional biomarker-based diagnosis of Alzheimer’s disease.

Click here to watch the clip.

Susan M. Landau, PhD, Helen Wills Neuroscience Institute, University of California, Berkeley, talks about her presentation “Comparing Predictors of Conversion: Data from the Alzheimer’s Disease Neuroimaging Initiative.”

Click here to watch the video clip.

Dawn Matthews, Chief Executive Officer and President, Abiant, Inc, discusses “Hippocampal Glucose Metabolism Predicts Cognitive Decline and Correlates to Disease Progression in the ADNI Population.”

Click here to play the video clip.

Additional video footage from Tuesday, including a Q&A press briefing with assembled members of the media, is available here.

Related Videos
The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert
Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:
Paul Appelbaum, MD: What to Warn Patients When Prescribing Psychedelics in the Future
Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John Kane, MD
Ryan McLaughlin, PhD: Challenges Studying Cannabis to Treat Psychiatric Illness
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Charles R. Marmar, MD: Blood Biomarkers for PTSD
John Kane, MD: Shifts in Antipsychotics for Schizophrenia
Andrew Chen, MD: Taking More Adverse Event Prone Anxiety Medications
© 2024 MJH Life Sciences

All rights reserved.